CLINICAL_TRIALS
trial_result
· 2013-09-30
Clinical Trial Update: Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma [Phase 3]
Summary
Phase 3 trial update on Nexavar-Tarceva combination as first-line therapy for hepatocellular carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2013-09-30